NCT02446483View on ClinicalTrials.gov

A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 19, 2014

Primary Completion Date

March 26, 2014

Study Completion Date

March 26, 2014

Conditions
Gastrointestinal Diseases
Interventions
DRUG

Idiazole 20mg DR tabs

Delayed release tablets containing 20 mg of rabeprazole

DRUG

PARIET 20 mg DR tabs

Orally administered, delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium.

Trial Locations (1)

Unknown

GSK Investigational Site, Cairo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02446483 - A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults | Biotech Hunter | Biotech Hunter